| Identification | Back Directory | [Name]
4-[BUTYL([2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL)AMINO]-5-PYRIMIDINECARBOXYLIC ACID | [CAS]
141872-46-0 | [Synonyms]
Abbott 81282
4-{butyl-[2′-(1H-tetra-zol-5-yl)-biphenyl-4-ylmethyl-]amino-}-pyrimidine-5-carboxy-lic acid
4-[BUTYL([2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL)AMINO]-5-PYRIMIDINECARBOXYLIC ACID
4-(N-n-Butyl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)amino)pyrimidine-5-carboxylic acid | [Molecular Formula]
C23H23N7O2 | [MDL Number]
MFCD00911676 | [MOL File]
141872-46-0.mol | [Molecular Weight]
429.47 |
| Hazard Information | Back Directory | [Uses]
A-81282 (Abbott 81282) is an antagonist of angiotensin II's AT1 receptor, with a pA2 value of 9.64 at the AT1 receptor in rabbit aorta. A-81282 also demonstrates significant inhibitory action on the binding of [125i]_Sar1_lle8_Angiotensin_ll to rat liver membranes, with a pKI value of 8.505. A-81282 has antihypertensive activity and can effectively lower blood pressure in renal artery-ligated rats[1]. | [IC 50]
AT1 Receptor: 9.64 (pA2) | [References]
[1] Hancock AA, et al. Pharmacological characterization of Abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptors. Life Sci. 1993;53(11):929-37. DOI:10.1016/0024-3205(93)90445-9 |
|
|